$NSTG News
Last published 1y ago
- 1y agoNSTGNanostring Technologies, INc. vs 10x Genomics, Inc. - AIA Trial, Settled After InstitutionUS Patent Trial and Appeal Board
- 1y agoNSTGNanostring Technologies, INc. vs 10x Genomics, Inc. - AIA Trial, Settled After InstitutionUS Patent Trial and Appeal Board
- 2y agoNSTG10x Genomics, Inc. et al. vs NanoString Technologies, Inc. - AIA Trial, Institution GrantedUS Patent Trial and Appeal Board
- 2y agoNSTGNanoString Announces Completion of Financing to Support Restructuring ProcessBusiness Wire$47.5 Million in New Financing Secured from Existing Noteholders, Upsized from Initial $40 million Commitment Supports Mission to Continue Serving Life Sciences Researchers Worldwide NanoString Technologies, Inc.
- 2y agoNSTGNanoString Takes Steps to Restructure Its Business and Protect Its Mission to Map the Universe of BiologyBusiness WireInitiates Voluntary Chapter 11 Restructuring Proceedings with Additional $40 Million in Financing Secured from Existing Noteholders to Facilitate Process Continuing to Serve Life Sciences Researchers
- 2y agoNSTGNanoString Launches the CosMx 6,000 plex RNA Assay and Showcases Whole Transcriptome Imaging CapabilityBusiness WireThree customers will present inaugural studies powered by the novel CosMx Whole Transcriptome Panel during annual AGBT meeting NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for
- 2y agoNSTGNanoString's CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell ResolutionBusiness WireMajor milestone marked by first public dataset released for CosMx Whole Transcriptome Panel with additional data forthcoming at the AGBT Meeting NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life
- 2y agoNSTGNanoString Reports Inducement Grants Under Nasdaq Listing RulesBusiness WireNanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 10
- 2y agoNSTGNanoString to Webcast Presentation from 42nd Annual J.P. Morgan Healthcare ConferenceBusiness WireNanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the
- 2y agoNSTGNanoString Comments on Delaware District Court VerdictBusiness WireNanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, commented on the November 17th verdict of a jury in the U.S. District Court for the
- 2y agoTXGNSTG10x Genomics Wins Another Patent Infringement Case Against NanoString TechnologiesPR Newswire10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that a jury in the U.S. District Court for the...
- 3y agoNSTGNanoString Technologies to Present Portfolio of Cutting-edge Brain Research and Novel Spatial Biology Applications for NeuroscienceBusiness WireTwenty-two posters and two symposia to be offered at Neuroscience 2023 NanoString Technologies, a leading provider of life sciences tools for discovery and translational research, announced today it will present at
- 3y agoNSTGNanoString to Webcast Presentations from Upcoming Healthcare ConferencesBusiness WireNanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two
- 3y agoNSTGNanoString Technologies, Inc. (NSTG) Q3 2023 Earnings Call TranscriptEarnings Call Transcripts
- 3y agoNSTGNanoString Technologies Releases Operating Results for Third Quarter of 2023Business WireCompleted Exchange Transaction with Convertible Note Holders Representing 94% of Outstanding Principal – Record Q3 Revenue of $48.1 Million, 63% Year on Year Growth and Above Upper End of Q3 Guidance Range
- 3y agoNSTGNanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel AvailableBusiness WireLeading researchers in breast and pancreatic cancer share first insights utilizing the GeoMx Immuno-oncology Proteome Atlas NanoString Technologies, a leading provider of life sciences tools for discovery and
- 3y agoNSTGTXG10x Genomics Comments on Second UPC Preliminary Injunction DecisionPR NewswireUPC Denies Second Preliminary Injunction Request; Prior Injunctions Against NanoString's CosMx Products in Europe Remain in Full Effect
- 3y agoNSTGNanoString Provides Preliminary Financial and Operational Highlights for Third Quarter of 2023Business Wire- Record Q3 Revenue of Over $48 Million, 63% Year on Year Growth, Above Upper End of Q3 Guidance Range - - Implementing Reorganization of R&D and Manufacturing Operations to Improve Path to Profitability
- 3y agoNSTGA*STAR's Genome Institute of Singapore, NanoString and Next Level Genomics Establish Joint Lab to Advance Studies of Complex Diseases with Spatial GenomicsBusiness WireA*STAR's Genome Institute of Singapore (GIS), NanoString® Technologies, Inc. (NASDAQ:NSTG), and Next Level Genomics (NLG), today announced the establishment of a joint laboratory in Singapore focusing on the
- 3y agoNSTGTXG10x Wins Injunction From Unified Patent Court Banning Sales of NanoString's CosMx Products in EuropePR NewswireSecond Injunction Issued Against CosMx
- 3y agoNSTGNanoString Comments on Unified Patent Court OrderBusiness WireNanoString Will Immediately Appeal Preliminary Injunction Temporarily Blocking NanoString's Ability to Market and Sell CosMx Spatial Molecular Imager Products for RNA Detection within UPC Member Countries in
- 3y agoNSTGNanoString to Host Virtual Spatial Genomics Summit September 19Business WireFifth annual event will explore the latest advancements in spatial biology highlighting new products and customer success stories NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools
- 3y agoNSTGNanoString Launches the Most Comprehensive Spatial Proteomics Panel Ever OfferedBusiness WireEmpowering researchers to spatially profile more than 500 proteins simultaneously in FFPE tissue using abcam's IHC-validated immuno-oncology antibody portfolio NanoString Technologies (NASDAQ:NSTG), a leading provider
- 3y agoNSTGNanoString Expands Partnerships with Contract Research Organizations Making Spatial Molecular Imaging Tools Widely Available to Global BioPharma ResearchersBusiness WireMacrogen, Inc., Propath UK, and Sirona Dx Add CosMx Spatial Molecular Imager to Meet Growing Demand for Spatial Biology Tools for Drug Developers NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life
- 3y agoNSTGNanoString to Webcast Presentations from Upcoming Healthcare ConferencesBusiness WireNanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two
- 3y agoNSTGNanoString Appoints Todd Garland as Chief Commercial OfficerBusiness WireNanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for discovery and translational research, today announced that Todd Garland has been appointed Chief Commercial Officer, effective August 28,
- 3y agoNSTGNanoString Platforms Advance Groundbreaking Studies of Immune Response in Pig-to-Human Organ TransplantsBusiness WireAugust Issue of Lancet Medical Journal Features Breakthrough Study Decoding Immunological Challenges of Xenotransplantation NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for
- 3y agoNSTGNanoString to Webcast Presentations from Upcoming Healthcare ConferencesBusiness WireNanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two
- 3y agoNSTGDelaware District Court Permits NanoString's Counterclaims that 10x Genomics and Harvard Violated the Antitrust LawsBusiness Wire10x and Harvard now must defend against allegations that they "are pursuing an ill-gotten monopoly by enforcing patents that are subject to a requirement that they be licensed non-exclusively" NanoString Technologies,
- 3y agoNSTGNanoString Provides Preliminary Financial and Operational Highlights for Second Quarter of 2023Business Wire- Record Q2 Revenue of Over $44 Million, 37% Year on Year Growth and Above Upper End of Q2 Guidance Range - - New Orders for CosMx Instruments Grew Sequentially and Year on Year - NanoString Technologies, Inc.
- 3y agoNSTGNanoString Reports Inducement Grants Under Nasdaq Listing RulesBusiness WireNanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 23
- 3y agoNSTGNanoString Reports Inducement Grants Under Nasdaq Listing RulesBusiness WireNanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 23
- 3y agoNSTGAcrobat Genomics, NanoString, and Illumina Accelerator Collaborate with Stanford Medicine to Discover New Drug Targets for Gene Editing-Based TherapeuticsBusiness WireAcrobat Genomics, NanoString Technologies, Inc. (NASDAQ:NSTG), and the Illumina Accelerator announced today their collaboration with Stanford Medicine to discover new drug targets for gene editing-based therapeutics
- 3y agoNSTGOwkin Powers a New Era in Oncology Research with MOSAIC – An Unprecedented $50 Million Spatial Atlas of Cancer CellsBusiness Wire– Cutting-edge spatial omics technologies to map cancer cells and their immune environment in high resolution, allowing AI to unlock potential for new breakthrough treatments – – Landmark research project is 100x
- 3y agoNSTGTXG10x Genomics Files Two New Lawsuits Requesting Preliminary Injunctions Against NanoString's CosMx ProductsPR NewswireAlso Files New Suit Against Vizgen's MERSCOPE Products for Patent Infringement PLEASANTON, Calif., June 1, 2023 /PRNewswire/ -- 10x Genomics, Inc. (NASDAQ:TXG), a leader in single cell and spatial biology, today
- 3y agoNSTGNanoString to Webcast Presentation from Jefferies Healthcare ConferenceBusiness WireNanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the
- 3y agoNSTGNanoString to Host Conference Call on Monday, May 22, 2023, to Provide Comments on Decision of the Regional Court of MunichBusiness WireNanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will host a conference call on Monday, May 22, 2023, at
- 3y agoNSTGNanoString Responds to Decision of the Regional Court of MunichBusiness WireNanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today responded to the Regional Court of Munich's recent decision finding that NanoString's
- 3y agoNSTGTXG10x Genomics Wins Permanent Injunction Against NanoString's CosMx ProductsPR Newswire10x Genomics is seeking additional injunctions to protect its intellectual property PLEASANTON, Calif., May 17, 2023 /PRNewswire/ -- 10x Genomics, Inc. (NASDAQ:TXG), a leader in single cell and spatial biology, today
- 3y agoNSTGNanoString Technologies Releases Operating Results for First Quarter of 2023Business Wire– Q1 Revenue of $35.8 Million – – Total Spatial Biology and nCounter Revenue Above Upper End of Q1 Guidance Ranges – – Raising Annual Revenue Guidance to $175-185 Million – NanoString Technologies, Inc.
- 3y agoNSTGNanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023Business WireNanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report first quarter 2023 operating results after the
- 3y agoNSTGNanoString Reports Inducement Grants Under Nasdaq Listing RulesBusiness WireNanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 16
- 3y agoNSTGNVDANanoString to Webcast Panel on AI-Based Genomics and Drug Discovery from the 43rd Annual Cowen Health Care ConferenceBusiness WireNanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to participate in a panel discussion,
- 3y agoNSTGNanoString Technologies Releases Fourth Quarter and Full Year 2022 Operating Results and Provides 2023 Financial OutlookBusiness Wire- Generated Record Orders for Over 105 Spatial Biology Instruments, Representing 50% Growth Year-over-Year - - Q4 Revenue Over $34 Million - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life
- 3y agoNSTGNanoString to Webcast Presentation from the 43rd Annual Cowen Health Care ConferenceBusiness WireNanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the
- 3y agoNSTGNanoString to Release Fourth Quarter and Fiscal Year 2022 Operating Results and Host Conference Call on Tuesday, February 28, 2023Business WireNanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report fourth quarter and fiscal year 2022 operating
- 3y agoNSTGNanoString Showcases Ultra High-Plex 6K RNA Single Cell Imaging at the 2023 Advances in Genome Biology and Technology (AGBT)Business WireGold Sponsor Workshop Unveils Roadmap to Extend Single Cell Imaging to 6,000-Plex RNA and 120-Plex Protein for the CosMx Spatial Molecular Imager NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life
- 3y agoNSTGWeill Cornell Medicine and NanoString Collaborate to Create Comprehensive Spatial Atlas of Human AnatomyBusiness WireFirst comprehensive spatial atlas of healthy human tissue from multiple organs, including multi-cell and single cell resolution using both GeoMx and CosMx NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider
- 3y agoNSTGNanoString Releases Single Cell Spatial Transcriptomics Dataset Highlighting Data Quality of CosMx Spatial Molecular ImagerBusiness WireNew liver tissue dataset highlights high sensitivity and specificity of CosMx system, and the biological power of spatially analyzing 1000 RNA targets NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of
- 3y agoNSTGNanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2022Business WireGenerated Record Orders for Over 105 Spatial Biology Instruments in Q4, Representing 50% Growth Year-over-Year Q4 Product and Service Revenue of Over $34 Million, Within Guidance Range of $33 to $35 Million NanoString